Phoenix Rising Group imagines a future world where humans will gradually replace all of their body parts with enhanced parts and will reemerge like phoenixes from humans to bionic hybrids, through 3D Printing, Gene Editing, Cell Manipulation, and Silicon Wafer Integration.
Registered in Delaware with operations in Silicon Valley and India, the company is inspired by the Theseus Paradox that an object (such as a ship) that gradually has all of its components replaced remains fundamentally the same and yet totally different.
The company focuses on exploring technologies related to human repair, regeneration, and medical innovation. The group works at the intersection of biology, engineering, and materials science, with an emphasis on understanding how emerging technologies can be applied in practical and commercially viable ways over time.
Its work is research-driven and long-term in nature, starting with early-stage exploration and progressing selectively into areas that show clear potential. As capabilities develop, Phoenix Rising Group aims to support the development of products or businesses in relevant fields, working with partners and specialists where appropriate.
Areas under development include 3D printing of human bones using a patient’s own cells or advanced biomaterials, integration of microprocessors with the human brain, regeneration or replacement of organs through cell-based therapies and advanced materials, the application of gene-editing technologies such as CRISPR to treat or potentially cure inherited genetic diseases, and the development of advanced cellular engineering techniques to improve the function, resilience, and regenerative capacity of healthy human cells. The group also explores other emerging technologies that have the potential to transform human health and longevity.